Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
- PMID: 28716861
- DOI: 10.1182/blood-2017-04-775841
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Comment in
-
Are outcomes of allografts for CLL still relevant?Blood. 2017 Sep 21;130(12):1393-1394. doi: 10.1182/blood-2017-08-798561. Blood. 2017. PMID: 28935644 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical